News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FOUSE JACQUALYN A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 10,718 shares
@ $28.36, valued at
$304k
Exercised 23,900 options to buy
@ $0 |
|
| 06/16/2023 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 2,505 shares
@ $0
Granted 11,294 options to buy
@ $61.44, valued at
$693.9k
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 291 shares
@ $66.64, valued at
$19.4k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 170,000 options to buy
@ $29.46, valued at
$5M
Granted 47,800 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 280 shares
@ $79.42, valued at
$22.2k
|
|
| 02/23/2022 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,674 shares
@ $29.08, valued at
$106.8k
Exercised 12,379 options to buy
@ $0 |
|
| 02/16/2022 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,505 shares
@ $30.5, valued at
$106.9k
Exercised 11,334 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 289 shares
@ $73.4, valued at
$21.2k
|
|
| 10/04/2021 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 271 shares
@ $68.78, valued at
$18.6k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,398 shares
@ $0
Exercised 11,333 restricted stock units
@ $0 |
|
| 02/12/2021 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 163,000 options to buy
@ $56.68, valued at
$9.2M
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2020 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,282 shares
@ $0
Granted 10,514 options to buy
@ $98.68, valued at
$1M
|
|
| 04/15/2020 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,673 shares
@ $40.64, valued at
$149.3k
Exercised 12,379 options to buy
@ $0 |
|
| 04/02/2020 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 270 shares
@ $73.23, valued at
$19.8k
|
|
| 03/24/2020 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on DICK'S SPORTING GOODS, INC.|
Txns:
| Granted 9,518 shares
@ $0 |
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 203 shares
@ $84.96, valued at
$17.2k
|
|
| 05/31/2019 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 1,400 restricted stock units
@ $0 |
|
| 04/29/2019 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,520 shares
@ $0
Granted 12,472 options to buy
@ $75.03, valued at
$935.8k
|
|
| 04/05/2019 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on DICKS SPORTING GOODS INC|
Txns:
| Granted 4,181 shares
@ $0 |
|
| 04/02/2019 |
4
| FOUSE JACQUALYN A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 145 shares
@ $86.01, valued at
$12.5k
|
|
| 02/05/2019 |
4
| FOUSE JACQUALYN A (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 350,346 options to buy
@ $53.87, valued at
$18.9M
Granted 42,695 options to buy
@ $0 |
|
|
|
|